ExVivo Labs, ProteinQure and iBionics Accepted to Canadian Technology Accelerator San Francisco

EXVIVO, ProteinQure and iBionics are participating in the Winter 2018 cohort of the Canadian Technology Accelerator (CTA) San Francisco – Life Sciences, an intensive program that offers Canadian companies the opportunity to expand their business in a global hub for the life sciences sector.

Click here to read more

Previous
Previous

OBIO Completes Successful Canadian Health Investment Showcase in New York City

Next
Next

Thornhill Medical Named Finalist at the 2018 Ontario Export Awards